Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel L. Valinsky, S. Simhoni, R. Bassal, V. Agmon, R. Yishai, M.S.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Vaccines for the elderly

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

L. Boyanova Clinical Microbiology and Infection

High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China X.-S. Chen, Y.-P. Yin, W.-H. Wei, H.-C. Wang,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

M.L. McMorrow, M. Aidoo, S.P. Kachur

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain A. Doménech-Sánchez Clinical Microbiology.

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Non-antibiotic strategies for sepsis

An eye-catching acanthocephalan

E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul

Prevalence of Toscana virus antibodies in residents of Croatia

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

Vector control: a cornerstone in the malaria elimination campaign

Prevalence of antibodies to phleboviruses within the sand fly fever Naples virus species in humans, northern Greece V. Anagnostou, A. Papa Clinical.

High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China Y. Cao, V. Minhas, X. Tan,

Training for the infectious diseases speciality in Norway

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health R.M. Davies Clinical Microbiology and Infection

H. Völzke, K. M. Kloker, A. Kramer, L. Guertler, M. Dören, S. E

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Curtailed short-term and long-term survival following infection with non-typhoid Salmonella in Israel M. Weinberger, S. Yaron, V. Agmon, R. Yishai, A.

Transmission permeability of tuberculosis involving immigrants, revealed by a multicentre analysis of clusters N. Alonso Rodríguez, S. Andrés, E. Bouza,

Detection of, and frequent co-infection with, human bocavirus in faecal specimens from children in Wuhan, China Y. Huang, P. Mao, H. Wang Clinical Microbiology.

Laboratory diagnosis of Clostridium difficile disease

A case of pleurisy associated with antibodies to Rickettsia conorii

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

A.P. Underwood, J. Green Clinical Microbiology and Infection

Vaccines for the elderly

C. Gagliotti, L. Nobilio, M.L. Moro

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain J.-Y. Wang, H.-L.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel L. Valinsky, S. Simhoni, R. Bassal, V. Agmon, R. Yishai, M.S. Green, D. Cohen Clinical Microbiology and Infection Volume 12, Issue 10, Pages 968-973 (October 2006) DOI: 10.1111/j.1469-0691.2006.01504.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Percentage of subjects with diphtheria toxoid antibody levels ≤0.01 IU /mL (seronegative). Vertical bars indicate 95% CIs. Clinical Microbiology and Infection 2006 12, 968-973DOI: (10.1111/j.1469-0691.2006.01504.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Geometric mean concentration of diphtheria toxoid antibodies among subjects with individual antibody levels >0.01 IU/mL. Vertical bars indicate 95% CIs. Clinical Microbiology and Infection 2006 12, 968-973DOI: (10.1111/j.1469-0691.2006.01504.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions